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ScienceDirect
journal homepage: www.elsevier .com/locate /rmedLETTER TO THE EDITORMtDNA depletions and deletions may also be
important in pathogenesis of lung cancerDear editor,
We read the article by Sylvia et al. titled “Mitochondrial
DNA mutations in exhaled breath condensate of patients
with lung cancer” [1]. In this study, aim of authors is to
investigate importance of mutations of mitochondrial DNA
(mtDNA) in pathogenesis of lung cancer. The exhaled
breath condensate (EBC) and saliva have been analyzed for
mitochondrial DNA D loop changes using a PCR sequencing
approach. Authors have found significantly elevated D-loop
mutation rate in the lung cancer group compared to the
control groups. Especially, T16217C substitution has been
shown specificity for lung cancer. They claimed that their
findings suggest that these processes are associated with
the carcinogenesis of lung cancer and may be a marker of
the disease. We share the authors’ scientific view, and think
that this study is well constructed and highly scientific.
However, we would like to express some constructive
criticism. We understand that the authors have considered
just point mutations in mtDNA. But, as known, there are
three major alterations of mtDNA: (i) point mutations, (ii)
large scale deletions and (iii) mtDNA depletions [2]. Anyone
of these alterations can be the cause of severe mitochon-
drial respiratory dysfunction, production of reactive oxygen
species which are known to contribute in cancer develop-
ment. For example, Leber’s hereditary optic neuropathy
occurs with a point mutation, KearneSayre syndrome is
caused by large scale deletions and mtDNA depletion may
express as Alpers’ syndrome.
There are studies in the literature investigating mtDNA
copy number and mtDNA deletions in lung cancer [3]. In
which, it has been shown that changes in mtDNA copy
number occur mtDNA deletions exist in lung cancer. We
wanted to add to this well written article that the mtDNA
variations other than point mutations may also have a role
in carcinogenesis of lung cancers.0954-6111/$ - see front matter ª 2013 Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.rmed.2013.04.024Declaration of interest
The authors report no conflicts of interest. The authors
alone are responsible for the content and writing of the
paper.
References
[1] Yang Ai SS, Hsu K, Herbert C, et al. Mitochondrial DNA muta-
tions in exhaled breath condensate of patients with lung can-
cer. Respir Med 2013 Mar 16. http://dx.doi.org/10.1016/j.
rmed.2013.02.007 pii:S0954-6111(13)00056-5.
[2] DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In:
Engel AG, Franzini-Armstrong C, editors. Myology, vol. II. Phil-
adelphia: McGrav Hill; 2004. p. 1623e76.
[3] Lee HC, Yin HC, Lin JC, et al. Mitochondrial genome instability
and mtDNA depletion in human cancers. Ann N Y Acad Sci 2005
May;1042:109e22.
Emin Ozgur Akgul
Gulhane Military Medical Academy and Medical School,
Department of Biochemistry, Turkey
Bulent Kurt*
Gulhane Military Medical Academy and Medical School,
Department of Pathology, Turkey
Yasemin Gulcan Kurt
Tuncer Cayci
Gulhane Military Medical Academy and Medical School,
Department of Biochemistry, Turkey*Corresponding author. GATA, Patoloji Anabilim Dalı, 06018
Etlik, Ankara, Turkey. Tel.: þ90 3123043716.
E-mail address: bkurt@gata.edu.tr
1 April 2013
Available online 31 August 2013.
